Researchers have engineered a chemically induced CRISPR system activated by near-infrared light, enabling precise spatiotemporal genome editing control. This platform expands upon the specificity of CRISPR-Cas systems by integrating light activation for enhanced regulation of editing events. The innovation promises to facilitate targeted therapeutic gene editing with minimized off-target effects, representing a significant advance in the gene therapy and biotechnology fields.